Rigel Pharmaceuticals
RIGL
#7467
Rank
NZ$0.55 B
Marketcap
$30.80
Share price
-2.35%
Change (1 day)
43.62%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2023 (TTM): -$0.37

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.39. In 2022 the company made an earnings per share (EPS) of -$0.61 a decrease over its 2021 EPS that were of -$0.18.

EPS history for Rigel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.37-39.2%
2022-$0.61240%
2021-$0.18-37.5%
2020-$0.29-60%
2019-$0.71-11.11%
2018-$0.80-26.23%
2017-$1.09-17.57%
2016-$1.3225.42%
2015-$1.05-42.72%
2014-$1.841.98%
2013-$1.80-24.06%
2012-$2.38-4.32%
2011-$2.48-290.41%
2010$1.30-126.64%
2009-$4.90-25.14%
2008-$6.5441.86%
2007-$4.6170.86%
2006-$2.70-27.4%
2005-$3.72-33.33%
2004-$5.57-37.73%
2003-$8.95-31.83%
2002-$13.13-63.55%
2001-$36.02-96.43%
2000-$1,010

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.38 759.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.57 554.55%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.55-1,002.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
$25.28-6,531.82%๐Ÿ‡บ๐Ÿ‡ธ USA